Thermal ablation with magnetic resonance–guided focused ultrasound surgery (MRgFUS) is a noninvasive technique for treating fibroids and cancer. New research from UC Davis shows that combining the technique with chemotherapy can allow complete destruction of tumors in mice.
MRgFUS combines an ultrasound beam that heats and destroys tissue with a magnetic resonance imaging to guide the beam and monitor the effects of treatment. The effectiveness of the treatment can be limited by the need to spare normal tissue or critical structures on the tumor margins, as well as the need to eliminate micrometastases.
In a new paper in The Journal of Clinical Investigation, Katherine W. Ferrara, distinguished professor of biomedical engineering at UC Davis, and colleagues report on a strategy that can destroy an entire tumor without thermal destruction of the tumor margin. Her group demonstrated a dramatic increase in the concentration of anti-cancer chemotherapy within several types of MRgFUS thermal ablation-treated tumors.
“MRgFUS is already FDA approved for the treatment of uterine fibroids and palliation of bone metastases. We hope to expand the indication for MRgFUS by supplementing it with chemotherapy,” said first author Andrew Wong, a graduate student with the UC Davis Physician Scientist Training Program.
Ferrara’s previous research has shown that ultrasound-induced mild hyperthermia can enhance the accumulation of tiny nanoparticles carrying anti-cancer drugs, but the accumulation is dependent on the type of tumor. Her group hypothesized that combining thermal ablation and chemotherapy could improve efficacy across multiple types of tumors.
The team used a variety of techniques including combined positron emission tomography/computed tomography (PET-CT), magnetic resonance imaging, autoradiography, and fluorescence imaging to track nanoparticles loaded with the chemotherapy drug doxorubicin in a mouse model of breast cancer.
They found that as the ultrasound damaged the tumor and induced a local immune response, nanoparticles accumulated in the tumor and the local drug concentration increased 50-fold. The high drug concentrations continued over several weeks, increasing total exposure of the tumor to the drug.
Ferrara’s research team found that the enhanced drug accumulation induced by MRgFUS resulted in improved survival and a consistent cure in their preclinical model of breast cancer, even when part of the tumor was left intact.
They also demonstrated that an effective cure could be achieved with a carefully designed protocol involving heat-activated nanoparticles, which, when gently heated by ultrasound, release their chemotherapeutic payload in the vasculature surrounding the tumor.
The Latest on: MRgFUS
via Google News
The Latest on: MRgFUS
- Ultrasound Delivers Antibody Therapy to Breast Cancer Metastases in the Brainon October 15, 2021 at 1:49 pm
MR-guided focused ultrasound (MRgFUS) is a noninvasive technology that has shown promise in delivering drugs across a temporarily permeable BBB, but has not been proven in humans. Now, in a ...
- Can A New Ultrasound Test Help Treat Brain Cancer Patients By Getting Drugs To The Brain?on October 13, 2021 at 12:43 pm
A new ultrasound testing technique was found to have the potential to deliver drugs to the brain for treatment of neurodegenerative diseases and even cancer.
- Ultrasound trial offers hope for brain cancer patientson October 13, 2021 at 10:14 am
A trial in four women whose breast cancer had spread to the brain showed that magnetic resonance-guided focused ultrasound (MRgFUS) could safely deliver the antibody therapy Herceptin into their ...
- InSightec to Share Key Insights and Progress at the 4th Focused Ultrasound International Symposiumon October 11, 2021 at 5:00 pm
InSightec, world leader in MR-guided Focused Ultrasound (MRgFUS) will be on site at the Focused Ultrasound International Symposium (FUS) to share key insights gained in the past two years of using ...
- MR-Guided Focused Ultrasound for the Novel and Innovative Management of Osteoarthritic Knee Painon October 10, 2021 at 5:00 pm
MRgFUS treatment had a potential of rapid and long-lasting pain alleviation without adverse side effects. Significant increase of PPTs on treated area showed successful denervation effect on the ...
- MR-Guided Focused Ultrasound for the Novel and Innovative Management of Osteoarthritic Knee Painon September 28, 2021 at 5:00 pm
This is the first report of clinical application of MRgFUS for knee OA. Real-time monitoring of the sonication area and temperature elevation enabled performance of safe and accurate treatment.
- Ultrasound technology used for first time to treat uncontrollable tremorson June 23, 2021 at 3:16 am
More than £2 million has been raised by the University of Dundee to purchase the Magnetic Resonance-guided Focused Ultrasound (MRgFUS) technology. It uses sound waves to help destroy tissue that ...
- Missing Treatment Optionon July 11, 2019 at 6:51 pm
The authors discuss numerous treatments of fibroids (1), including MR-guided focused ultrasound surgery (MRgFUS/MRgHIFU). However, no reference is made to the option of ultrasound-guided high ...
via Bing News